Redhill Biopharma - ADR

NASDAQ:RDHL   3:59:54 PM EDT
5.12
+0.13 (+2.60%)
Other Pre-Announcement

RedHill Biopharma Reports Q2 Loss Per Ordinary Share Of 6 Cents

Published: 08/26/2021 11:50 GMT
Redhill Biopharma - ADR (RDHL) - Redhill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights.
Redhill Biopharma Ltd - Qtrly Loss per Ordinary Share $0.06.
Redhill Biopharma Ltd - Net Revenues Were Approximately $21.5 Million for Q2 of 2021, an Increase of $0.9 Million Compared to Q1 of 2021.
Redhill Biopharma - Cash Balance As of June 30, 2021, Was Approximately $71.5 Million.